What's News - Bumrungrad International Hospital What's News RSS Feed

Bumrungrad International Hospital The First and Only Hospital in Asia, and Third Worldwide, to Implement CardioInsight Technology

15 June 2017 – Bumrungrad International Hospital has announced its launch of ‘CardioInsight’ – an innovative new noninvasive technology for the diagnosis of cardiac arrhythmia – making it the third hospital in the world, and the first in Asia, to implement this technology. The use of CardioInsight will help steer Bumrungrad International Hospital’s Arrhythmia Center toward its goal of being a leading hub for cardiac arrhythmia research and treatment, fully equipped with the latest technology and staffed by a team of world-class, highly experienced specialists.

CardioInsight system


Dr. Koonlawee Nademanee - Director of the Pacific Rim Electrophysiology Research Institute in Los Angeles, USA and Cardiothoracic Physiologist at the Arrhythmia Center, Bumrungrad International, revealed that “The Arrhythmia Center at Bumrungrad International Hospital is pleased to announce another step forward in arrhythmia treatment with the introduction of ‘CardioInsight’ – a promising new non-invasive ECG based-technology to identify the mechanism and origin of a cardiac arrhythmia. Bumrungrad is one of the first three hospitals worldwide to have implemented this technology, the other two include the University Hospital of Bordeaux and Hammersmith Hospital in the UK. It is our goal to be the world’s leading center in the research and treatment of cardiac arrhythmia”.

CardioInsight’s founding and leadership team, Charu Ramanathan and Ryan Bokan were also present at the press conference for the launch of CardioInsight at Bumrungrad International Hospital. The team was very complementary of the collaboration with Bumrungrad and remarked that it offered a unique and world-class opportunity to help patients as well as perform transformational research in the treatment of difficult cardiac arrhythmias. The collaboration has started off at a strong pace under the leadership of Dr. Koonlawee Nademanee, a world expert in the treatment of these complex arrhythmias, with fifty patients treated already. The CardioInsight team (now Medtronic) was confident that the outcome of the Bumrungrad collaboration will have a major impact in the understanding and treatment of cardiac arrhythmia, and be able to build a new foundation of knowledge in this field for the world-wide medical community .

Cardiac arrhythmia is considered a ‘silent danger’ which can cause permanent damage to the heart – or even lead to death. Symptoms may only occur intermittently, but some people may have some signs and symptoms, such as light-headedness, fainting, palpitations, shortness of breath, feeling tight-chested, and loss of consciousness.

Many patients may not present any symptoms while visiting the doctor for a diagnosis, and therefore, do not receive treatment. Thus, the ability to pinpoint the cause of an abnormality with a precise diagnosis is even more important , as is the ability to deliver accurate and effective treatments. All of these factors rely on the experience of the physicians, together with the modern technology at their disposal.


The CardioInsight system uses a vest embedded with electrodes which detect electrical signals from the heart at 252 points across the chest. This system combines the data with heart anatomy from a CT scan and produces patient-specific 3D images of the electrical rhythm of the heart for each heart beat and where the abnormalities are occurring. The most important aspect of CardioInsight is that it is completely noninvasive and no tools or equipment are required to be inserted into a patient’s body, and the results also supplement invasive procedures, such as heart surgery, making it easier to reach specific points. If we were to compare CardioInsight to an ECG (Electrocardiogram) in detecting an abnormality in a heart’s atrium, CardioInsight would not only be able to detect the abnormality, but be able to pinpoint the specific area of the abnormality as well.

Dr. Koonlawee concluded with a final statement by saying, “ In addition to the effective treatment technologies we have at present, another success factor in arrhythmia treatment relies on the equally high level of experience of the physicians and specialist teams. We have implemented CardioInsight because it is our goal to be the world’s leading center for arrhythmia research and treatment. This tool helps us to learn more, and understand the disease more, both of which allow us to give patients the best diagnoses and the most suitable treatments”.


Arrhythmia Center

Bumrungrad International Clinic (BIC) Building, 14th floor, Bumrungrad International Hospital, Bangkok, Thailand


For appointments or inquiries

Tel: +66 (0) 2667 1000
Online Appointment: Make appointment here
Learn more: Ask us a question